Log in

NASDAQ:PRPHProPhase Labs Stock Price, Forecast & News

$1.59
-0.12 (-7.02 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.59
Now: $1.59
$1.68
50-Day Range
$1.60
MA: $1.71
$1.99
52-Week Range
$1.47
Now: $1.59
$3.07
Volume1,541 shs
Average Volume2,365 shs
Market Capitalization$18.43 million
P/E RatioN/A
Dividend YieldN/A
Beta0.03
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over-the-counter(OTC) consumer healthcare products, dietary supplements, and other remedies in the United States. The company offers TK Supplements product line include Legendz XL for sexual health; Triple Edge XL, an energy booster and testosterone support; and Super ProstaFlow+ for prostate and urinary health. In addition, the company provides contract manufacturing services of OTC healthcare and dietary supplements products. It markets its products through national chain, regional, specialty, and local retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.04 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PRPH
CUSIPN/A
Phone215-345-0919

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.88 million
Book Value$0.92 per share

Profitability

Net Income$-3,150,000.00

Miscellaneous

Employees47
Market Cap$18.43 million
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive PRPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PRPH and its competitors with MarketBeat's FREE daily newsletter.

ProPhase Labs (NASDAQ:PRPH) Frequently Asked Questions

How has ProPhase Labs' stock been impacted by COVID-19 (Coronavirus)?

ProPhase Labs' stock was trading at $2.0301 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PRPH shares have decreased by 21.7% and is now trading at $1.59. View which stocks have been most impacted by Coronavirus.

When is ProPhase Labs' next earnings date?

ProPhase Labs is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for ProPhase Labs.

How were ProPhase Labs' earnings last quarter?

ProPhase Labs Inc (NASDAQ:PRPH) posted its earnings results on Tuesday, May, 12th. The company reported ($0.07) earnings per share for the quarter. The company had revenue of $1.89 million for the quarter. ProPhase Labs had a negative net margin of 31.15% and a negative return on equity of 22.80%. View ProPhase Labs' earnings history.

How often does ProPhase Labs pay dividends? What is the dividend yield for ProPhase Labs?

ProPhase Labs announced a dividend on Wednesday, November 20th. Investors of record on Tuesday, December 3rd will be paid a dividend of $0.25 per share on Thursday, December 12th. The ex-dividend date of this dividend is Monday, December 2nd. View ProPhase Labs' dividend history.

Has ProPhase Labs been receiving favorable news coverage?

Headlines about PRPH stock have trended somewhat negative on Saturday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. ProPhase Labs earned a daily sentiment score of -1.1 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutProPhase Labs.

Who are some of ProPhase Labs' key competitors?

What other stocks do shareholders of ProPhase Labs own?

Who are ProPhase Labs' key executives?

ProPhase Labs' management team includes the following people:
  • Mr. Ted William Karkus, Chairman & CEO (Age 60)
  • Ms. Monica Brady, CFO & Chief Accounting Officer (Age 42)

What is ProPhase Labs' stock symbol?

ProPhase Labs trades on the NASDAQ under the ticker symbol "PRPH."

How do I buy shares of ProPhase Labs?

Shares of PRPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ProPhase Labs' stock price today?

One share of PRPH stock can currently be purchased for approximately $1.59.

How big of a company is ProPhase Labs?

ProPhase Labs has a market capitalization of $18.43 million and generates $9.88 million in revenue each year. ProPhase Labs employs 47 workers across the globe.

What is ProPhase Labs' official website?

The official website for ProPhase Labs is www.prophaselabs.com.

How can I contact ProPhase Labs?

ProPhase Labs' mailing address is 621 NORTH SHADY RETREAT ROAD, DOYLESTOWN PA, 18901. The company can be reached via phone at 215-345-0919 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.